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Abstract
Motivation: The increasing amount of peer-reviewed manuscripts requires the development of
specific mining tools to facilitate the visual exploration of evidence linking diseases and proteins.
Results: We developed TIN-X, the Target Importance and Novelty eXplorer, to visualize the associ-
ation between proteins and diseases, based on text mining data processed from scientific litera-
ture. In the current implementation, TIN-X supports exploration of data for G-protein coupled
receptors, kinases, ion channels, and nuclear receptors. TIN-X supports browsing and navigating
across proteins and diseases based on ontology classes, and displays a scatter plot with two pro-
posed new bibliometric statistics: Importance and Novelty.
Availability and Implementation: http://www.newdrugtargets.org
Contact: cbologa@salud.unm.edu
1 Introduction
Science builds upon past discoveries, traditionally communicated
through scientific literature. However, scale-out of traditional and
alternate publication modes has exceeded the limits of human
processing (Hunter and Cohen, 2006), creating the need for
computer-assisted methods. Text mining, ontologies, and interactive
visualization are some of the emerging technologies that can allevi-
ate information overload. We present a new method and software
tool utilizing these technologies, to provide biomedical scientists
with rankings and visualizations linking proteins and diseases. The
information is derived from PubMed abstracts, text mined using
previously published tools for named entity recognition (NER) of
gene/protein and disease names (Pletscher-Frankild et al., 2015). We
propose two new bibliometric indices based on NER mentions, spe-
cifically devised to address research planning use cases. Our goal is
to enable scientists to identify research subjects with sufficient evi-
dence of importance, but not already well-studied, with focus on tar-
get prioritization for drug discovery. Novelty estimates the scarcity
of publications about a protein target (see also Equation 1).
Importance estimates the strength of the association between that
protein target and a specific disease (see also Equation 2). By visual-
izing Novelty and Importance on a 2D plot, users can easily examine
the strength of the evidence linking protein targets and diseases of
interest.
TIN-X is a web application which allows users to navigate tar-
gets via the drug target ontology (DTO, http://drugtargetontology.
org) and diseases via the disease ontology (DO) (Kibbe et al., 2015).
In its current implementation, TIN-X allows users to query, browse
and display disease-target associations for the following protein
families: ion channels, G-protein coupled receptors (GPCRs),
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nuclear receptors (NRs) and kinases. These plots are interactive,
with built-in drill-down and link-out functionality for in-depth
examination of selected targets. TIN-X was inspired by and devel-
oped for the Illuminating the Druggable Genome (IDG)
Knowledge Management Center (KMC, http://targetcentral.ws),
which aggregates and integrates protein-centric information, and
seeks to identify and prioritize understudied genes and proteins
for further investigation and validation as potentially novel drug
targets.
2 Methods and implementation
TIN-X is implemented in Scala using the Lift web framework
(http://liftweb.net). The back-end utilizes a PostgreSQL database
derived from the IDG-KMC knowledge base known as Target
Central Research Database (TCRD) (Nguyen et al., 2017). TCRD
compiles data from over 50 genomic, proteomic and drug-centric
sources, and relies on the Disease Ontology, as well as in-network
(IDG-KMC) developed tools such as DTO and disease—genes/pro-
tein mapping using a highly efficient dictionary-based NER applica-
tion (Pafilis et al., 2013) with dictionaries from the DISEASES
(Pletscher-Frankild et al., 2015) database, respectively. Data are
extracted, transformed, aggregated and loaded into TCRD, with
routine updates quarterly. All PubMed abstracts are downloaded
from NCBI FTP site. Bibliometric statistics and the derived Novelty
(Ni) and Importance (Iij) scores are pre-computed for runtime per-
formance, using the following formulae:
Ni ¼ 1=
X
k
1
Tk
(1)
Iij ¼
X
k
1
Tk Dk
(2)
where Tk and Dk are the numbers of targets and diseases in abstract (k),
respectively, and summation over all publications including target (i),
and for importance, also including disease (j). Fractional counts are
employed to reflect strength of association. For example, if an abstracts
mentions three targets once, each receives a fractional count 1/T¼ 1=3.
3 Application example
In Figure 1, TIN-X displays targets for a selected disease, ‘glucose
intolerance’. The DO hierarchy can be navigated in the left panel,
and the targets are plotted with log–log Importance–Novelty axes.
Searching by disease name and by target name (with auto-suggest) is
supported. In the current layout, targets with stronger associations
are in the upper part of the plot, while targets with a higher number
of publications are on the left side of the plot. In general, more inter-
esting associations will be on the upper right boundary of the plot,
where data points represent non-dominated solutions to the multi-
objective optimization maximizing both Importance and Novelty.
Targets can be filtered based on Target Development Level, with
Tclin representing mode-of-action drug targets (Santos et al., 2017),
and Tdark representing the understudied proteins (Nguyen et al.,
2017). Targets can be filtered by protein superfamily (e.g. GPCRs).
Link outs to Pharos (targets) and DO (diseases) are provided for
each association. Figure 2 illustrates the result of mouse-over actions
for the target from Figure 1, ‘Chemokine-like receptor 1’
(CMKLR1), which links to 6 publications associating CMKLR1 and
glucose intolerance. Titles and citations are displayed. Clicking on
each article reveals full abstracts and links out to complete PubMed
records, where users can examine the available evidence.
4 Conclusions and future directions
TIN-X provides an interactive visualization, ranking, and prioritiza-
tion platform for scientists interested in exploring potentially novel
drug targets, and examining the relationship between diseases, dis-
ease categories, proteins and protein classes, using automated text
mining of biomedical literature. As with all current text mining,
Fig. 1. Screenshot of TIN-X. The disease, glucose intolerance, was queried. Mouse-over displays information about a specific data point, in this case, CMKLR1
(Color version of this figure is available at Bioinformatics online.)
2602 D.C.Cannon et al.
Downloaded from https://academic.oup.com/bioinformatics/article-abstract/33/16/2601/3111842
by Kobenhavns Universitets user
on 02 January 2018
TIN-X cannot replace expert human readers and curators, yet, it is
increasingly clear that automated bibliometry is essential given the
accelerated pace and volume of publications. TIN-X is an important
interactive tool in the IDG project, and future plans include adding
functionality relating to known drugs and drug classes, and inclu-
sion of additional protein classes. More information about Tclin,
Tdark and other target development levels can be found at http://
www.nature.com/nrd/posters/druggablegenome/
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Fig. 2. Screenshot of TIN-X. Click on selected point shows the papers where the target protein (CMKLR1) might be relevant to the disease (glucose intolerance)
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